Klivira
Request demo

Streamlining Medicaid Entyvio Prior Authorization Workflows

Navigating Medicaid Entyvio prior authorization presents unique challenges due to state-specific regulations and varied managed care organization requirements. Klivira automates this complex process, ensuring compliance and efficiency.

For revenue cycle directors and prior authorization coordinators, managing specialty drug PAs under Medicaid demands precision. Entyvio, a high-volume prior authorization target, requires navigating a complex landscape of state-level criteria and diverse managed care organization (MCO) protocols. Inefficient workflows lead to delays and potential denials, impacting patient access and revenue integrity.

The Nuances of Entyvio Prior Authorization in Medicaid

Entyvio (vedolizumab) is an integrin receptor antagonist indicated for moderate to severe ulcerative colitis and Crohn's disease. As a high-cost specialty medication, it consistently requires prior authorization across payer types, including Medicaid. The complexities are amplified by Medicaid's dual delivery models and state-specific criteria, which vary significantly from one state to another.

Medicaid's Dual Prior Authorization Pathways

Medicaid prior authorization processes are bifurcated based on the state's delivery model. For Fee-for-Service (FFS) beneficiaries, PA requests route through the state Medicaid agency's fiscal agent, often via a state-specific portal. For the majority enrolled in Medicaid Managed Care, authorizations are handled by contracted MCOs such as Centene subsidiaries, Molina, UHC Community Plan, or Anthem Medicaid plans, each with their own distinct provider portals and submission requirements.

Navigating State-Specific Entyvio Criteria

Medicaid medical necessity criteria for specialty drugs like Entyvio are established at the state level, published in state Medicaid agency policy libraries. MCOs cannot impose criteria more restrictive than the state's baseline. Klivira's platform accounts for these state-specific rules and identifies the responsible MCO's specific requirements, ensuring accurate submission tailored to the appropriate policy.

Key Considerations for Medicaid Entyvio PA Submissions

  • Verification of the beneficiary's Medicaid delivery model (FFS vs. Managed Care).
  • Identification of the specific MCO and its unique provider portal or X12 278 routing capabilities.
  • Adherence to the state Medicaid agency's published medical necessity criteria for Entyvio.
  • Understanding of potential D-SNP coordination requirements for dual-eligible Medicare and Medicaid members.
  • Accurate documentation of prior treatment failures or contraindications as per policy.

Interoperability and Regulatory Impact on Medicaid MCOs

Medicaid managed-care organizations are designated impacted payers under CMS-0057-F. This rule mandates specific PA decision timeframes (72-hour standard, 24-hour expedited) and requires the implementation of FHIR-based Prior Authorization APIs on a phased timeline. Klivira's integrations align with these evolving interoperability standards, streamlining data exchange and preparing providers for future requirements.

Klivira's Approach to Medicaid Entyvio PA Automation

Klivira automates the identification of the correct Medicaid pathway, whether FFS or through an MCO. Our platform integrates with various state Medicaid portals and MCO provider portals, routing Entyvio prior authorization requests accurately while aligning with state-specific criteria. This reduces manual effort, accelerates decision cycles for this high-volume specialty drug, and helps manage the state-by-state variation inherent in Medicaid.

Frequently asked questions

What are the primary channels for submitting Entyvio prior authorizations for Medicaid members?

For Medicaid Fee-for-Service (FFS) members, submissions typically go through the state Medicaid agency's portal. For Medicaid Managed Care members, prior authorizations are submitted via the specific Managed Care Organization's (MCO) provider portal, or through X12 278 routing where supported by the payer.

How do Medicaid Managed Care Organizations (MCOs) affect Entyvio PA?

Medicaid MCOs, such as Centene subsidiaries or Molina, administer benefits for the majority of Medicaid members. Each MCO has its own provider portal and specific prior authorization processes, although their medical necessity criteria for drugs like Entyvio cannot be more restrictive than the state Medicaid program's baseline.

Are there specific state-level requirements for Entyvio PA under Medicaid?

Yes, Medicaid prior authorization requirements for specialty drugs like Entyvio are highly state-specific. Each state Medicaid agency publishes its own medical necessity criteria, which MCOs must adhere to. Providers must consult the relevant state Medicaid policy library for the most current guidelines.

Does CMS-0057-F impact Entyvio prior authorizations for Medicaid?

CMS-0057-F directly impacts Medicaid Managed Care Organizations (MCOs), requiring them to adhere to specific prior authorization decision timeframes (e.g., 72-hour standard, 24-hour expedited) and implement FHIR-based Prior Authorization APIs. Traditional Fee-for-Service Medicaid is less directly impacted by the API requirements but benefits from broader interoperability provisions.

How does Klivira handle dual-eligible (Medicare-Medicaid) members needing Entyvio PA?

Klivira's platform is designed to identify and coordinate prior authorization for dual-eligible members. This involves understanding the primary payer (often Medicare) and the secondary payer (Medicaid), ensuring that submissions account for both sets of rules and any specific D-SNP coordination requirements to streamline the process.

Related coverage

Other entyvio prior authorization by payer

Other entyvio prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo